RARE News

Pomerantz LLP Reminds Shareholders with Losses on their Investment in Ultragenyx Pharmaceutical Inc. of Class Action Lawsuit – RARE

RARE DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Ultragenyx Pharmaceutical (RARE) Investors of Securities Class Action Deadline on April 6, 2026

RARE SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Ultragenyx Pharmaceutical Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!

Pomerantz LLP Shares Class Action Details With Shareholders in Ultragenyx Pharmaceutical Inc. – RARE

Pomerantz LLP Reminds Shareholders with Losses on their Investment in Ultragenyx Pharmaceutical Inc. – RARE

RARE DEADLINE NOTICE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Ultragenyx Pharmaceutical Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RARE

Ultragenyx Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Ultragenyx Pharmaceutical Inc. - RARE

RARE DEADLINE NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Ultragenyx Pharmaceutical Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RARE

Pomerantz LLP Shares Class Action Details With Investors in Ultragenyx Pharmaceutical Inc. – RARE

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)